126 related articles for article (PubMed ID: 3826937)
1. [Non-Hodgkinś lymphoma in childhood, preliminary results of the LSA2 L2 protocol modified by high-dose methotrexate].
Prats Viñas J; Gallego Melcón S; Pérez Payarols J; Macía Martí J; Sánchez de Toledo J
An Esp Pediatr; 1987 Jan; 26(1):15-21. PubMed ID: 3826937
[TBL] [Abstract][Full Text] [Related]
2. [Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
Cubells Riero J; Pardo García N; Turmo Martí J; Vela Ferrer E; Badía Torroella RM; González Rivero MA; Illa Sala J; Melo Valls M
An Esp Pediatr; 1988 Sep; 29(3):203-7. PubMed ID: 3195869
[TBL] [Abstract][Full Text] [Related]
3. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
4. Nasal-paranasal-oronasopharyngeal lymphomas in childhood: the role of staging system on prognosis.
Yariş N; Kutluk T; Yalçin B; Akyüz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2000; 17(5):345-53. PubMed ID: 10914044
[TBL] [Abstract][Full Text] [Related]
5. [Non-Hodgkin's lymphomas in childhood: results of treatment in patients in stage III].
Maluf Júnior PT; Britto JL; Cristofani L; Almeida MT; Odone Filho V
Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(6):278-82. PubMed ID: 8029600
[TBL] [Abstract][Full Text] [Related]
6. [Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
Shimamoto Y; Imai S; Endo N
Gan To Kagaku Ryoho; 1992 Mar; 19(3):395-8. PubMed ID: 1543367
[No Abstract] [Full Text] [Related]
7. Non-Hodgkin's lymphoma in children; diffuse lymphoblastic histology; diffuse non-lymphoblastic histology; LSA2-L2 experience.
Wollner N
An Esp Pediatr; 1988 Oct; 29 Suppl 34():122-6. PubMed ID: 3214018
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
10. [Treatment and prognosis of children with relapsed non-Hodgkin's lymphoma--a report from CCLSG-NHL 890 Study. Children's Cancer and Leukemia Study Group (CCLSG)].
Tsurusawa M; Katano N; Asami K; Watanabe A; Koizumi S; Miyake M; Kikuta A; Iwai A; Yamamura Y; Kawano Y; Mugishima H; Sekine I; Matsushita T; Horikoshi Y; Kikuchi M; Anami K; Fujimoto T
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1695-702. PubMed ID: 11057320
[TBL] [Abstract][Full Text] [Related]
11. [Lymphoblastic non-Hodgkin's lymphoma: estimation of the survival of patients with the disseminated form of the disease (stages III and IV) treated by the LSA2-L2 protocol].
Pisón Garcés J; Buñuel Alvarez JC; Domínguez Fenollé MP; Castillo Laita JA; Cenarro Guerrero T; Monreal Gálvez MJ; Arana Navarro T; Hernández Gayá A
An Esp Pediatr; 1991 Dec; 35(6):381-4. PubMed ID: 1793185
[TBL] [Abstract][Full Text] [Related]
12. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
[TBL] [Abstract][Full Text] [Related]
13. Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
Nachman J
Am J Pediatr Hematol Oncol; 1990; 12(3):359-66. PubMed ID: 2240485
[TBL] [Abstract][Full Text] [Related]
14. Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
Hvizdala EV; Berard C; Callihan T; Falletta J; Sabio H; Shuster JJ; Sullivan M; Wharam MD
J Clin Oncol; 1988 Jan; 6(1):26-33. PubMed ID: 3275750
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic results in 22 cases of childhood non-Hodgkin's lymphoma treated by ACOP combination chemotherapy].
Imashuku S; Arakawa S; Todo S; Esumi N; Shimizu Y; Fujiwara F; Tsunamoto K; Morioka Y; Sugimoto T; Fushiki S
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1086-93. PubMed ID: 3566305
[TBL] [Abstract][Full Text] [Related]
16. [The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)].
Vivanco Martínez JL; López Pérez J; Melero Moreno C; Torres Valdivieso MJ; Palacios López ME; Contra Gómez T; Martín Ramos N; Bernacer Borja M; Gil López C; Valverde Moreno F
An Esp Pediatr; 1998 Dec; 49(6):603-8. PubMed ID: 9972623
[TBL] [Abstract][Full Text] [Related]
17. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ
Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606
[TBL] [Abstract][Full Text] [Related]
18. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
[TBL] [Abstract][Full Text] [Related]
19. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
20. [Clinical, anatomo-pathologic aspects and therapeutic results in 63 malignant ORL non-Hodgkin's lymphomas in children].
Bergeron C; Patte C; Caillaud JM; Bernard A; Bayle C; Luboinski B; Hartmann O; Kalifa C; Flamant F; Lemerle J
Arch Fr Pediatr; 1989 Oct; 46(8):583-7. PubMed ID: 2604511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]